Novo Integrated Sciences, Inc. Common Stock
NVOS
NVOS was delisted on the 5th of November, 2024.
8 hedge funds and large institutions have $792K invested in Novo Integrated Sciences, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
14% more funds holding
Funds holding: 7 → 8 (+1)
0.04% less ownership
Funds ownership: 1.46% → 1.42% (-0.04%)
18% less capital invested
Capital invested by funds: $965K → $792K (-$173K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$42.8K |
| 2 |
BlackRock
New York
|
+$8.9K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.49K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$2.61K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$20 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$52K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |
NVOS Hedge Fund Activity: Q2 2022 in Review
8 of the 5,960 institutional investors tracked by Wall St. Rank reported a position in Novo Integrated Sciences, Inc. Common Stock (NVOS) for Q2 2022, worth a combined $792K — down 18% from $965K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new NVOS positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 1 trimmed.
The largest buyer was State Street, opening a new position worth an estimated $42.8K. The largest seller was CVI Holdings, exiting entirely with an estimated $52K sold.
- 8 institutional investors held Novo Integrated Sciences, Inc. Common Stock (NVOS) as of Q2 2022, up from 7 in Q1 2022.
- Funds reported $792K of Novo Integrated Sciences, Inc. Common Stock stock for Q2 2022, down 18% quarter-over-quarter.
- 2 funds opened new Novo Integrated Sciences, Inc. Common Stock positions in Q2 2022 and 1 closed out, a net change of +1 holder.
- The largest Novo Integrated Sciences, Inc. Common Stock buyer in Q2 2022 was State Street, an estimated $42.8K added.
- The largest Novo Integrated Sciences, Inc. Common Stock seller in Q2 2022 was CVI Holdings, an estimated $52K sold.
Based on aggregated 13F filings for Q2 2022.